FAQ

amidoxime reducing component, human

Known as: ARC enzyme, human, amidoxime reductase, human 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2016
0120002016

Related topics

Related topics

1 relation

Broader (1)

Oxidoreductase

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
amidoxime reducing component, human
Oxidoreductase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Quantifying the binding strength of salicylaldoxime-uranyl complexes relative to competing salicylaldoxime-transition metal ion complexes in aqueous solution: a combined experimental and…
The design of new ligands and investigation of UO2(2+) complexations are an essential aspect of reducing the cost of extracting… (More)
Is this relevant?
2013
2013
Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening.
A novel series of pyrazoline amidoxime (2a-d) and pyrazoly-1,2,4-oxadiazole (3a-p) and (4) of pharmacological significance have… (More)
Is this relevant?
2004
2004
New highly selective inhibitors of class II fructose-1,6-bisphosphate aldolases.
Phosphoglycolo amidoxime and phosphoglycolo hydrazide, two new derivatives of phosphoglycolic acid, were synthesised and… (More)
Is this relevant?
2002
2002
BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity.
Nephrotoxicity is one of the major dose limiting side effects of cisplatin chemotherapy. The antitumor and toxic effects are… (More)
Is this relevant?
2000
2000
BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
The protective effect of O-(3-piperidino-2-hydroxy-1-propyl)nicotinic amidoxime (BGP-15) against ischemia-reperfusion-induced… (More)
Is this relevant?